Advanced Instruments announced today at the American Association for Clinical Chemistry trade show in Chicago the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer.
Our newest osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. NORWOOD, Mass., July 26, 2022 /PRNewswire/ -- Advanced Instruments announced today at the American Association for Clinical Chemistry trade show in Chicago the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer. As the leading authority in osmometry, Advanced Instruments designed the OsmoPRO® MAX for clinical laboratories of all sizes seeking higher productivity through automation. The instrument's innovative flow-through technology eliminates manual pipetting and consumables, allowing testing to begin with the push of a button. The OsmoPRO MAX goes beyond providing accurate and precise test results to deliver a fully automated solution. The instrument provides increased efficiency and a simplified osmolality testing workflow:
The OsmoPRO MAX, like all of the osmometers in Advanced Instruments' portfolio, uses the industry-preferred freezing point depression method to provide reliable results in minutes. "The OsmoPRO MAX delivers the ease of use, automation, and data management features today's clinical laboratories seek," said Byron Selman, CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that our customers have depended on for the past 65 years." For Further Information: About Advanced Instruments
SOURCE Advanced Instruments, LLC |